Material Agreements

NXG NextGen Infrastructure Income Fund entered into Sub-Placement Agent Agreement with UBS Securities LLC valued at relating to the Common Shares to be offered under the Distribution Agreement (effective 2025-12-30).

“The Distributor has entered into a sub-placement agent agreement, dated December 30, 2025 (the “Sub-Placement Agent Agreement”), with UBS Securities LLC (the “Sub-Placement Agent”) relating to the Common Shares to be offered under the Distribution Agreement.”

NXG NextGen Infrastructure Income Fund entered into Distribution Agreement with Foreside Fund Services, LLC valued at up to 1,600,000 common shares of beneficial interest (effective 2025-12-30).

“On December 30, 2025, NXG NextGen Infrastructure Income Fund (NYSE: NXG) (the “Fund”) entered into a distribution agreement (the “Distribution Agreement”) with Foreside Fund Services, LLC (the “Distributor”), pursuant to which the Fund may offer and sell up to 1,600,000 common shares of beneficial interest of the Fund, par value $0.001 per share (the “Common Shares”), from time to time, through the Distributor, in transactions deemed to be “at the market” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Offering”).”

Glucotrack, Inc. entered into Securities Purchase Agreement with an investor valued at approximately $4.0 million (effective 2025-12-29).

“On December 29, 2025, Glucotrack, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with an investor (the “Investor”) for a private placement of securities”

Amplify Energy Corp. amended Second Amendment to Amended and Restated Credit Agreement with Citizens Bank, N.A. valued at $25,000,000 (effective 2025-12-31).

“On December 31, 2025, Amplify Energy Operating LLC (the “Borrower”), a wholly owned subsidiary of Amplify Energy Corp., a Delaware corporation (the “Company”), entered into the Borrowing Base Redetermination, Commitment Increase and Second Amendment to Amended and Restated Credit Agreement (the “Second Amendment”), among the Borrower, Amplify Acquisitionco LLC, the guarantors party thereto, the lenders party thereto and Citizens Bank, N.A., as administrative agent for the lenders.”

Profound Medical Corp. entered into Subscription Agreement with certain Canadian investors valued at aggregate gross proceeds of $6.45 million (effective 2025-12-30).

“On December 30, 2025, Profound Medical Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain Canadian investors (the “Investors”) providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares (the “Shares”), at a per share purchase price of $7.00 (the “Offering”) for aggregate gross proceeds of $6.45 million.”

UPEXI, INC. terminated Asset Management Agreement with GSR Strategies LLC (effective 2025-12-26).

“the Asset Management Agreement between the Company and GSR dated April 23, 2025 (the “AMA”) has been terminated effective December 26, 2025”

ZeroStack Corp. entered into Note Settlement Agreement with DeFi Development Corp. (effective 2025-12-29).

“On December 29, 2025, Flora Growth Corp. (the "Company") entered into a note settlement agreement (the "Note Settlement Agreement") with DeFi Development Corp. (the "Holder") pursuant to which the Solana-denominated convertible note issued to the Holder pursuant to the September 19, 2025 securities purchase agreement between the Company and the Holder (the "Note") was settled.”

SOCIETY PASS INCORPORATED. entered into Purchase Agreement with certain investors (effective 2025-12-29).

“Certain investors purchasing securities in the Offering entered into a securities purchase agreement with the Company (the “Purchase Agreement”), dated as of December 29, 2025.”

BioAtla, Inc. entered into Investment Agreement with Inversagen AI, LLC and Alliance International Resources Corp. valued at aggregate $40 million (effective 2025-12-30).

“On December 30, 2025, BioAtla, Inc. (“the Company” or “BioAtla”) entered into an Investment Agreement (the “Investment Agreement”) with Inversagen AI, LLC, a Delaware limited liability company (“Inversagen AI”), and Alliance International Resources Corp., a Nevada corporation (“AIRC”).”

Stardust Power Inc. entered into Securities Purchase Agreement with Lind Global Asset Management XIII LLC valued at approximately $4.0 million (effective 2025-12-23).

“On December 23, 2025, Stardust Power Inc. (the “Company”) entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management XIII LLC (“Lind”). Under the SPA, upon closing (which occurred on December 23, 2025) , the Company received gross proceeds of approximately $4.0 million”

Guerrilla RF, Inc. amended Amendment No. 3 to Amended and Restated Loan Agreement with Salem Investment Partners V, Limited Partnership (effective 2025-12-30).

“On December 30, 2025, the Company entered into Amendment No. 3 to Amended and Restated Loan Agreement (the “Salem Amendment”) with its primary lender, Salem Investment Partners V, Limited Partnership (“Salem”).”

Nuvve Holding Corp. entered into Securities Purchase Agreement with the Purchasers valued at $5,400,000 (effective 2025-11-14).

“On November 14, 2025, Nuvve Holding Corp. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with the purchasers identified therein (collectively, the “Purchasers”) providing for the issuance and sale to the Purchasers in a private placement (the “Private Placement”) of (i) shares of newly-designated Series A Convertible Preferred Stock, with par value $0.0001 per share and stated value of $1,000 per share (the “Series A Preferred Stock”) and (ii) accompanying warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”).”

Kodiak AI, Inc. terminated Venture Loan and Security Agreement, dated as of September 28, 2022, as amended with Horizon Technology Finance Corporation (effective 2025-12-31).

“On December 31, 2025, in connection with the entry into the Loan Agreement, the Borrowers terminated that certain Venture Loan and Security Agreement, dated as of September 28, 2022, as amended, by and between Legacy Kodiak and Lender.”

Kodiak AI, Inc. entered into Loan Agreement with Horizon Technology Finance Corporation valued at $30.0 million (effective 2025-12-31).

“On December 31, 2025 (the “ Closing Date ”), Kodiak AI, Inc., a Delaware corporation (the “ Company ”), and Kodiak Robotics, Inc., a Delaware corporation and subsidiary of the Company (“ Legacy Kodiak ”), as co-borrowers (together with the Company, the “ Borrowers ”), entered into a venture loan and security agreement (the “ Loan Agreement ”) by and among the Borrowers and Horizon Technology Finance Corporation, as collateral agent and lender (the “ Lender ”).”

ALPHA MODUS HOLDINGS, INC. entered into Securities Purchase Agreement with Alexander Haase-Dubosc valued at $110,000 (effective 2025-12-30).

“Effective December 30, 2025, Alpha Modus Holdings, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Alexander Haase-Dubosc (the “ Investor ”), pursuant to which the Company issued a convertible promissory note to the Investor in the original principal amount of $110,000”

Hut 8 Corp. amended Fourth Amended and Restated Credit Agreement with Coinbase Credit, Inc. valued at up to $200,000,000 (effective 2025-12-22).

“On December 22, 2025, Hut 8 Mining Corp., a British Columbia corporation (the “Borrower”), a wholly owned subsidiary of Hut 8 Corp. (the “Company”), entered into an amended and restated credit agreement (the “Fourth Amended and Restated Credit Agreement”) between the Borrower, as borrower, and Coinbase Credit, Inc. (“Coinbase”), as lender, collateral agent, and administrative agent. The Fourth Amended and Restated Credit Agreement amended and restated the Company’s existing credit agreement with Coinbase, dated as of June 26, 2023 and subsequently amended and restated on January 12, 2024, June 17, 2024 and June 16, 2025, and further amended on August 1, 2025 (as amended, the “Third Amended and Restated Credit Agreement”). The Fourth Amended and Restated Credit Agreement amends and restates the Third Amended and Restated Credit Agreement primarily to increase the principal amount by up to $70,000,000 of additional borrowings, if any, resulting in a total principal amount of up to $200,0”

New Mountain Net Lease Trust amended Second Amended and Restated Limited Partnership Agreement (effective 2025-12-31).

“On December 31, 2025, New Mountain Net Lease Trust, a Maryland statutory trust (the “Company”), on behalf of itself as the general partner and on behalf of the limited partners thereto, entered into that Second Amended and Restated Limited Partnership Agreement (the “Amended Operating Partnership Agreement”) of NEWLEASE Operating Partnership LP, a Delaware limited partnership and the operating partnership of the Company.”

Silicon Valley Acquisition Corp. entered into Private Placement Units Purchase Agreement with Silicon Valley Acquisition Sponsor LLC (effective 2025-12-22).

“● A Private Placement Units Purchase Agreement, dated December 22, 2025, between the Company and the Sponsor, a copy of which is filed as Exhibit 10.4 to this Report and incorporated herein by reference; ● A Private Placement Units Purchase Agreement, dated December 22, 2025, between the Company and the Representative,”

Silicon Valley Acquisition Corp. entered into Registration Rights Agreement with certain security holders (effective 2025-12-22).

“● A Registration Rights Agreement, dated December 22, 2025, among the Company and certain security holders, a copy of which is filed as Exhibit 10.3 to this Report and incorporated herein by reference; ● A Private Placement Units Purchase Agreement, dated December 22, 2025, between the Company and the Sponsor,”

Silicon Valley Acquisition Corp. entered into Investment Management Trust Agreement with Equiniti Trust Company, LLC (effective 2025-12-22).

“● A Warrant Agreement, dated December 22, 2025, between the Company and Equiniti Trust Company, LLC (“Equiniti”), as warrant agent, a copy of which is filed as Exhibit 4.1 to this Report and incorporated herein by reference; ● An Insider Letter Agreement, dated December 22, 2025, among the Company, its directors and officers and”

Silicon Valley Acquisition Corp. entered into Warrant Agreement with Equiniti Trust Company, LLC (effective 2025-12-22).

“● A Warrant Agreement, dated December 22, 2025, between the Company and Equiniti Trust Company, LLC (“Equiniti”), as warrant agent,”

Silicon Valley Acquisition Corp. entered into Underwriting Agreement with Clear Street LLC (effective 2025-12-22).

“he Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: ● An Underwriting Agreement, dated December 22, 2025, between the Company and Clear Street LLC (the “Representative”),”

Imunon, Inc. entered into Securities Purchase Agreement with a single healthcare-focused institutional investor valued at combined offering price of $3.61 per Share and Warrant (effective 2025-12-29).

“On December 29, 2025, Imunon, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single healthcare-focused institutional investor (the “Purchaser”) for a registered direct offering”

ACCENDRA HEALTH INC/VA/ amended Amended & Restated Receivables Purchase Agreement with PNC Bank, National Association, PNC Capital Markets LLC valued at $150 million.

“On the Closing Date, O&M Funding LLC (“ O&M Funding ”), as Seller, and Byram Healthcare Centers, Inc. (“ Byram ”), as initial Servicer, each a wholly-owned subsidiary of the Company, entered into an Amended & Restated Receivables Purchase Agreement (the “ Amended & Restated Receivables Purchase Agreement ”) with persons from time to time party thereto, as Purchasers, PNC Bank, National Association (“ PNC ”), as Administrative Agent, and PNC Capital Markets LLC, as Structuring Agent, pursuant to which accounts receivable with an aggregate outstanding amount not to exceed $150 million are sold”

DENTSPLY SIRONA Inc. entered into Note Purchase Agreement Amendments with noteholders party thereto valued at Amendments to three note purchase agreements dated December 11, 2015, October 27, 2016, and June 24, (effective 2025-12-24).

“On December 24, 2025, the Company entered into the following agreements (collectively, the “Note Purchase Agreement Amendments”): a. Note Purchase Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company and the noteholders party thereto with respect to the Note Purchase Agreement, dated as of December 11, 2015, by and among the Company and the other parties thereto; b. Note Purchase and Guarantee Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company, DENTSPLY DENTAL B.V. (as successor by merger to Sirona Dental Services GmbH) and the noteholders party thereto with respect to the Note Purchase Agreement and Guarantee Agreement, dated as of October 27, 2016, by and among the Company, Sirona Dental Services GmbH and the other parties thereto; and c. Note Purchase Agreement Amendment No. 4, dated as of December 24, 2025, by and among the Company and the noteholders party thereto with respect to the Note Purchase Agreement, dated as of”

DENTSPLY SIRONA Inc. entered into Second Amendment to Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at Amendment to revolving credit facility dated May 12, 2023, establishing new financial covenants incl (effective 2025-12-24).

“On December 24, 2025, DENTSPLY SIRONA Inc. (the “Company”) obtained the consent of the requisite lenders under its revolving credit facility, dated May 12, 2023, with JPMorgan Chase Bank, N.A., as administrative agent, to, among other things, amend certain provisions by entering into the Second Amendment to Credit Agreement, dated as of December 24, 2025 (the “Second Amendment to Credit Agreement”).”

Emmaus Life Sciences, Inc. entered into License and Exclusive Distribution Agreement with NeoImmuneTech, Inc. valued at an upfront payment (effective 2025-12-24).

“On December 24, 2025, Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” and the “company”) and NeoImmuneTech, Inc. (KOSDAQ: 950220.KQ), or NIT, entered into a License and Exclusive Distribution Agreement, or License Agreement, dated as of the same day pursuant to which we granted NIT an exclusive (including as to Emmaus) license to all our rights to market, sell and distribute Endari® (prescription grade L-glutamine oral powder) and any generic equivalents, or the Products, in sickle cell disease, or the Field, in the U.S. and its territories and possession and Canada, referred to as the Territory, in exchange for an upfront payment and a royalty on NIT’s Product sales.”

AXT INC entered into Underwriting Agreement with Northland Securities, Inc., as representative of the underwriters valued at approximately $87 million (effective 2025-12-29).

“On December 29, 2025, AXT, Inc., a Delaware corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Northland Securities, Inc., as representative of the underwriters named therein (the “Underwriters”) related to the offer and sale of shares of the Company’s common stock (the “Offering”).”

ON24 INC. entered into Agreement and Plan of Merger with Cvent Atlanta, LLC and Summit Sub Corp. valued at $8.10 per share (effective 2025-12-29).

“On December 29, 2025, ON24, Inc., a Delaware corporation (the “ Company ” or “ ON24 ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Cvent Atlanta, LLC, a Delaware limited liability company (“ Parent ”), and Summit Sub Corp., a Delaware corporation and wholly-owned subsidiary of Parent (“ Merger Sub ”).”

MEDICINOVA INC entered into Sales Agreement with Lucid Capital Markets, LLC valued at $50,000,000 (effective 2025-12-29).

“On December 29, 2025, MediciNova, Inc. (the “Company”) entered into an equity distribution agreement with Lucid Capital Markets, LLC (“Agent”) to sell shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from time to time through the Agent, acting as sales agent, having a maximum aggregate offering price of $50,000,000 (the “Sales Agreement”).”

COLLEGIUM PHARMACEUTICAL, INC terminated Second Amended and Restated Loan Agreement with Biopharma Credit PLC, as collateral agent (effective 2025-12-23).

“On December 23, 2025, in connection with its entry into the Credit Agreement, the Company repaid in full all obligations outstanding under the Existing Credit Agreement.”

COLLEGIUM PHARMACEUTICAL, INC entered into Credit Agreement with Truist Bank, as administrative agent valued at $580,000,000 term loan, $300,000,000 of delayed draw term loan commitments, and a $100,000,000 revol (effective 2025-12-23).

“On December 23, 2025, Collegium Pharmaceutical, Inc. (the “Company”) entered into a Credit Agreement by and among the Company, the lenders from time to time party thereto and Truist Bank, as administrative agent (the “Credit Agreement”).”

HOULIHAN LOKEY, INC. entered into A&R Voting Trust Agreement with the trustees named therein (effective 2025-12-30).

“On December 30, 2025, Houlihan Lokey, Inc. (the “Company”) entered into an amended and restated voting trust agreement (the “A&R Voting Trust Agreement”), by and among the Company and the trustees named therein (collectively, the “Trustees”).”

Clean Energy Technologies, Inc. entered into a equity purchase with two other investors valued at $283,855 (effective 2025-12-29).

“Effective December 29, 2025, the Company entered into two additional subscription agreements (together with the Subscription Agreement the “ Subscription Agreements ”) with two other investors pursuant to which the Company sold the two other investors an aggregate of 656,158 shares of Company common stock (together with the Initial Shares the “ Shares ”) for $283,855.”

Clean Energy Technologies, Inc. entered into Subscription Agreement with an investor valued at $395,328 (effective 2025-12-24).

“Effective December 24, 2025, Clean Energy Technologies, Inc. (the “ Company ”), entered into a subscription agreement (the “ Subscription Agreement ”) with an investor pursuant to which the Company sold the investor 913,842 shares of Company common stock (the “ Initial Shares ”) for $395,328.”

SOBR Safe, Inc. entered into Registration Rights Agreement with certain institutional investors (Purchasers) valued at Company shall file resale registration statement within 20 calendar days; to be effective within 60 (effective 2025-12-24).

“On December 24, 2025, the Company and the Purchasers entered into a Registration Rights Agreement (the "Registration Rights Agreement") whereby the Company has undertaken to file a resale registration statement covering all of the shares of Common Stock, shares underlying the Warrants, and shares underlying the Placement Agent Warrants.”

SOBR Safe, Inc. entered into Placement Agent Agreement with H.C. Wainwright & Co., LLC valued at cash placement fee equal to 7.5% of the gross cash proceeds received at Closing (effective 2025-12-22).

“On December 22, 2025, the Company entered into a letter of engagement (the "Placement Agent Agreement") with HCW, pursuant to which HCW agreed to serve as the exclusive placement agent for the Company in connection with the Private Placement.”

SOBR Safe, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $2,000,002.20 (effective 2025-12-24).

“On December 24, 2025, SOBR Safe, Inc., a Delaware corporation (the "Company"), entered into a private placement transaction (the "Private Placement"), pursuant to a Securities Purchase Agreement (the "Purchase Agreement") with certain institutional investors (the "Purchasers") for aggregate gross proceeds of $2,000,002.20, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement.”

CEMTREX INC entered into Securities Purchase Agreement with a single accredited institutional investor valued at aggregate gross proceeds of $2,000,000 (effective 2025-12-30).

“On December 30, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”

Turtle Beach Corp amended First Amendment to Credit Agreement with Bank of America, N.A., as administrative agent, swingline lender and L/C issuer (effective 2025-12-29).

“On December 29, 2025, Turtle Beach Corporation (the “Company”) entered into the First Amendment to Credit Agreement (the “First Amendment”), which amended the Company’s credit agreement, dated as of August 1, 2025 (as amended from time to time, the “Credit Agreement”), by and among the Company, the other borrowers and guarantors party thereto, the lenders from time to time party thereto, and Bank of America, N.A., as administrative agent, swingline lender and L/C issuer.”

Presurance Holdings, Inc. entered into Securities Purchase Agreement with Clarkston Companies, Inc. valued at eight million dollars ($8,000,000) (effective 2025-12-23).

“On December 23, 2025 (the "Initial Issue Date"), Presurance Holdings, Inc. (the "Company") sold one thousand six hundred (1,600) shares of its newly designated Series C Preferred Stock, no par value (the "Series C Preferred Stock" or the "Securities"), to Clarkston Companies, Inc. (the "Purchaser"), an entity affiliated with Jeffrey Hakala, a member of the Board of Directors of the Company, for an aggregate purchase price of eight million dollars ($8,000,000). The sale of the Securities was consummated on the Initial Issue Date pursuant to a Securities Purchase Agreement (the "Agreement") by and between the Company and the Purchaser.”

CYPHERPUNK TECHNOLOGIES INC. terminated November 2025 CoinXit RSUs Agreement with CoinXit Ltd. valued at Termination and cancellation of 2,411,700 RSUs (effective 2025-12-23).

“Pursuant to the December 2025 CoinXit RSUs Agreement, the Company and CoinXit also agreed (i) to terminate and cancel the November 2025 CoinXit RSUs issued pursuant to the November 2025 CoinXit RSUs Agreement, and (ii) to treat the grant by the Company to CoinXit of the December 2025 CoinXit RSUs as satisfying in full all of the Company’s obligations under the Consulting Agreement to grant CoinXit 5,448,157 RSUs under the Company’s equity incentive plans.”

CYPHERPUNK TECHNOLOGIES INC. entered into December 2025 CoinXit RSUs Agreement with CoinXit Ltd. valued at Grant of 5,448,157 RSUs (effective 2025-12-23).

“On December 23, 2025, the Compensation Committee of the Board approved the grant under the Company’s 2025 Equity Incentive Plan (the “2025 Plan”) of 5,448,157 RSUs to CoinXit (the “December 2025 CoinXit RSUs”), pursuant to a Restricted Stock Unit Grant Agreement, dated December 23, 2025 (the “December 2025 CoinXit RSUs Agreement”).”

Penguin Solutions, Inc. entered into Stock Transfer Agreement with Lexar Europe B.V. valued at $46.08 million for 19% interest in Zilia (effective 2025-12-29).

“On December 29, 2025, SMART Modular Technologies (LX) S.à r.l. (“Seller”), a société à responsabilité limitée governed by the laws of the Grand Duchy of Luxembourg and a wholly owned indirect subsidiary of Penguin Solutions, Inc. (the “Company”), entered into that certain Stock Transfer Agreement (the “Stock Transfer Agreement”), by and among Seller, Lexar Europe B.V., a company organized under the laws of the Netherlands (“Buyer”), Zilia Technologies Indústria e Comércio de Componentes Eletrônicos Ltda., a sociedade limitada governed by the laws of Brazil (“Zilia”), Shenzhen Longsys Electronics Co., Ltd., a company limited by shares governed by the laws of the People’s Republic of China and, as of the date hereof, listed on the Shenzhen Stock Exchange (Stock Code: 301308) (“Parent”), and Shanghai Intelligent Memory Semiconductor Co., Ltd. ( 上海慧 忆半导体有限公司 ), a limited liability company governed by the laws of the People’s Republic of China (“Parent Funding Entity”, together with Buyer a”

Medalist Diversified, Inc. terminated Loan Agreement with Farmers and Merchants Bank of Long Beach valued at $14,700,000 (effective 2025-12-30).

“On December 30, 2025, using cash on hand and the proceeds from previously announced property dispositions, the Company completed the repayment in full all outstanding indebtedness under and terminated (i) the Loan Agreement (the "Loan Agreement"), dated as of July 18, 2025, by and between MDRR XXV Depositor 1, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company, and Farmers and Merchants Bank of Long Beach ("Farmers"), (ii) the Continuing Guaranty, dated as of July 18, 2025, by the Company in favor of Farmers (the "Company Guaranty") and (iii) the Continuing Guaranty, dated as of July 18, 2025, by Medalist Diversified Holdings, LP (the "Operating Partnership") in favor of Farmers (the "Operating Partnership Guaranty").”

Medalist Diversified, Inc. entered into Parkway Purchase and Sale Agreement with Club Forest International Parkway, LLC valued at $7,900,000 (effective 2025-12-29).

“On December 29, 2025, (the "Effective Date"), MDR Parkway, LLC, a Delaware limited liability company ("MDR Parkway"), a wholly-owned subsidiary of Medalist Diversified REIT, Inc., a Maryland corporation (the "Company") and PMI Parkway, LLC, a Delaware limited liability company not affiliated with the Company (together with MDR Parkway, the "Sellers"), entered into a Purchase and Sale Agreement (the "Parkway Purchase and Sale Agreement"), with Club Forest International Parkway, LLC, a Virginia limited liability company (the "Purchaser"), whereby the Purchaser agreed to acquire (the "Acquisition") the property located at 2697 International Parkway, Virginia Beach, Virginia, commonly known as the Parkway Property (the "Parkway Property").”

DigitalBridge Group, Inc. entered into Agreement and Plan of Merger with Duncan Holdco LLC (effective 2025-12-29).

“On December 29, 2025 (the “Signing Date”), DigitalBridge Group, Inc., a Maryland corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Duncan Holdco LLC, a Delaware limited liability company (“Parent”), Duncan Sub I Inc., a Maryland corporation and wholly owned subsidiary of Parent (“Merger Sub I”), Duncan Sub II LLC, a Delaware limited liability company and wholly owned subsidiary of Merger Sub I (“Merger Sub II”), and DigitalBridge Operating Company, LLC, a Delaware limited liability company (“Company OP”).”

ProPetro Holding Corp. entered into Master Lease Agreement with Stonebriar Commercial Finance LLC valued at $350 million (effective 2025-12-29).

“ProPetro Energy Solutions, LLC (“ProPetro Energy Solutions”), a wholly owned subsidiary of the Company, entered into an Interim Funding Agreement and a Master Lease Agreement with Stonebriar Commercial Finance LLC (“Stonebriar”) for the right, but not the obligation, to fund up to $350 million of purchases of power generator equipment.”

ProPetro Holding Corp. entered into Interim Funding Agreement with Stonebriar Commercial Finance LLC valued at $350 million (effective 2025-12-29).

“ProPetro Energy Solutions, LLC (“ProPetro Energy Solutions”), a wholly owned subsidiary of the Company, entered into an Interim Funding Agreement and a Master Lease Agreement with Stonebriar Commercial Finance LLC (“Stonebriar”) for the right, but not the obligation, to fund up to $350 million of purchases of power generator equipment.”

ProPetro Holding Corp. amended Amendment No. 3 to Amended and Restated Credit Agreement (effective 2025-12-26).

“Effective December 26, 2025, ProPetro Holding Corp. (the “Company”) entered into an amendment to its Amended and Restated Credit Agreement.”